There are 50 million children under the age of 15 living with asthma in sub-Saharan Africa; most of them are reportedly in South Africa. For parents or caregivers of these children managing the illness can be complicated and stressful. Added to that, new information suggests that asthma treatment needs urgent re-examining, leaving parents with questions about the dangers of being over reliant on reliever pumps.
Doctor Marlin McKay, a GP at the Goldman Medical Centre in Johannesburg explains, “When children are diagnosed with the respiratory disease, they are normally prescribed with two different types of inhalers, a maintenance inhaler and a symptom relieving inhaler. 2,3 Findings show that patients with asthma - not precluding children, will frequently underuse the maintenance inhaler which contains an anti-inflammatory therapy, and instead, over-rely on the symptom reliever inhaler. It is usually blue in colour and contains an item which opens up the airways known as short-acting beta2 agonists (SABA) therefore providing rapid and temporary relief for children. The problem with this approach is it can mask the worsening of symptoms and actually increases their risk of asthma attacks.”4-7
Guest on the line: Doctor Marlin McKay, a GP at the Goldman Medical Centre in Johannesburg